ObsEva SA
(NASDAQ : OBSV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.22%177.900.7%$1343.27m
MRKMerck & Co., Inc. 0.44%91.570.7%$1172.95m
PFEPfizer Inc. -1.23%51.790.9%$1100.09m
LLYEli Lilly & Co. -1.12%320.611.1%$1034.00m
BMYBristol-Myers Squibb Co. -0.96%76.261.0%$998.17m
ABBVAbbVie, Inc. -0.75%152.021.9%$951.59m
AZNAstraZeneca Plc -1.01%65.401.0%$437.00m
SGENSeagen Inc. 0.64%178.075.7%$317.91m
TPTXTurning Point Therapeutics, Inc. -0.12%75.160.0%$287.74m
GSKGSK Plc -0.23%43.430.2%$275.82m
HZNPHorizon Therapeutics Plc 0.75%80.365.4%$163.02m
NVSNovartis AG -0.98%83.700.2%$162.95m
MRTXMirati Therapeutics, Inc. 3.45%69.451.6%$151.78m
ALNYAlnylam Pharmaceuticals, Inc. 1.31%147.768.1%$142.36m
NVONovo Nordisk A/S -0.75%110.600.1%$142.16m

Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.